Patient no. | Sex | Age (y) | Histologic diagnosis of LGG (WHO grade II) | Confirmation of histology | Diagnosis of LGG before baseline PET | Initial treatment of LGG before baseline PET | Initial treatment of LGG after baseline PET | Time between initial diagnosis and malignant progression (mo) | Histologic diagnosis after malignant progression | WHO grade | Confirmation of histology |
1 | M | 56 | A | Resection | Yes | Resection | Resection | 106 | AA | III | Resection |
2 | M | 36 | A | Resection | Yes | Resection | Resection | 64 | AOA | III | Resection |
3 | M | 33 | A | Biopsy | No | No | WW | 44 | AOA | III | Resection |
4 | F | 40 | A | Resection | Yes | Resection | Resection | 53 | AA | III | Resection |
5 | M | 43 | A | Biopsy | No | No | WW | 4 | GBM | IV | Resection |
6 | M | 11 | A | Biopsy | No | No | WW | 15 | AA | III | Biopsy |
7 | F | 48 | A | Biopsy | No | No | WW | 5 | AA | III | Resection |
8 | M | 38 | OA | Resection | No | No | Resection | 15 | AOA | III | Resection |
9 | M | 85 | A | Resection | No | No | Resection | 10 | AA | III | Resection |
10 | F | 28 | E | Resection | No | No | Resection | 19 | E | III | Resection |
11 | M | 40 | ODG | Biopsy | No | No | WW | 11 | AODG | III | Biopsy |
12 | M | 47 | A | Biopsy | No | No | WW | 29 | AA | III | Biopsy |
13 | M | 50 | ODG | Resection | No | No | RTx, CTx | 21 | GBM | IV | Resection |
14 | M | 27 | A | Biopsy | No | No | Resection | 22 | AA | III | Resection |
15 | M | 64 | A | Resection | No | No | Resection | 16 | GBM | IV | Biopsy |
16 | M | 51 | A | Resection | Yes | Resection | Resection | 83 | AA | III | Resection |
17 | F | 57 | A | Biopsy | No | No | WW | 21 | GBM | IV | Biopsy |
18 | M | 43 | A | Biopsy | Yes | WW | WW | 25 | AOA | III | Biopsy |
19 | M | 40 | OA | Biopsy | Yes | WW | WW | No malignant progression | OA | II | Resection |
20 | M | 24 | A | Biopsy | No | No | WW | No malignant progression | OA | II | Resection |
21 | M | 49 | OA | Biopsy | Yes | RTx | CTx | No malignant progression | OA | II | Resection |
22 | M | 56 | A | Resection | No | No | WW | No malignant progression | A | II | Resection |
23 | F | 20 | OA | Biopsy | No | No | CTx | No malignant progression | OA | II | Resection |
24 | F | 54 | A | Biopsy | No | No | WW | No malignant progression | A | II | Biopsy |
25 | F | 43 | A | Biopsy | No | No | RTx, CTx | No malignant progression | A | II | Resection |
26 | F | 62 | OA | Resection | No | No | CTx | No malignant progression | OA | II | Resection |
27 | M | 45 | A | Resection | No | No | RTx | No malignant progression | A | II | Biopsy |
A = astrocytoma; AA = anaplastic astrocytoma; AOA = anaplastic oligoastrocytoma; WW = watch-and-wait strategy; GBM = glioblastoma; OA = oligoastrocytoma; E = ependymoma; ODG = oligodendroglioma; AODG = anaplastic oligodendroglioma; RTx = radiation therapy; CTx = chemotherapy.